DSM DSM
Company Profile ↓Company Overview
DSM (DSM) is a publicly traded company listed on with a market capitalization of $262.47M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 8.1.
Carries low leverage with a debt-to-equity ratio of 0.36.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Nov 2025 Revenue of $-4.57M (-113.6% YoY); net profit $-5.52M.
- Trailing 12 Months Year-on-year growth — revenue -113.6%, earnings -117.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -113.64% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -117.02% |
Stock Price Performance
| 1 Year: | -7.01% |
| 6 Months: | -8.92% |
| 3 Months: | -8.37% |
| 1 Month: | +1.15% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)52.23 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|
| Revenue | - | -70.38M | 10.06M | 33.49M | -4.57M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 1.07M | 967.00K | 1.09M | 947.69K |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 1.98M | 5.08M | 6.55M | 5.88M |
| Pretax Income | - | -71.45M | 9.09M | 32.40M | -5.52M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -71.45M | 9.09M | 32.40M | -5.52M |
| Diluted EPS | 0.50 | -1.46 | 0.19 | 0.66 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 492.71M | 487.14M | 522.84M | 495.88M |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | 48.11K | 333.82K | 722.87K | - | 681.41K |
| Inventory | - | - | - | - | - |
| Receivables | - | 7.66M | 7.35M | 7.56M | 7.59M |
| Total Liabilities | - | 118.75M | 167.39M | 181.37M | 172.08M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 116.41M | 113.56M | 125.38M | 117.84M |
| Total Equity | - | 373.96M | 319.75M | 341.48M | 323.80M |
| Shares Outstanding | - | 49.43M | 49.43M | 49.43M | 49.43M |
Cash Flows (Annual)
Figures in USD.
| Metric | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 38.83M | 15.70M | -1.87M | 20.13M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | -38.54M | -15.32M | 1.15M | -19.45M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | 38.83M | 15.70M | -1.87M | 20.13M |
| Net Change in Cash | - | 285.71K | 389.06K | -722.87K | 681.41K |
Ratios (Annual)
Figures in %.
| Metric | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 101.5% | 90.4% | 96.8% | 120.7% |
| ROE % | - | -19.1% | 2.8% | 9.5% | -1.7% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DSM
Insider Stock Purchases: October 20, 2026 - Moomoo
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPOUZyT1Z0anZ5aVBHaE9idWNobmh0ZmRkY3RsZmVyMzctX0duek54bXkySE9rV0ZCei1hbnlSejVybVJlZU9uN3JNdjdsdXZwdnZFbnJFNXdYdUduWjJhbWgwWm5qS2xFYWZ5b3FPUUZQMXhBdnNaMmNYdXp2aW5udE50clB1bjlGQ1pB?o…
DSM Firmenich AG - Sponsored ADR (DSFIY) Is Up 4.82% in One Week: What You Should Know - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQeFJ0dzVRa09tekFCSjVBdU4yR0VmZ0ljaEN4N2pPLV9HaklsOUhIR2NwdU1yVUtZOEZKeHNjRl95RDVDOWt0VTIxaDJLNkV4NVhRajR5SWJLMUlENWc3OTJJQUNfYkV2VkZ1cUpGa1VzUEg4QXNDZWFray10Wm9qbEtYR01pdmNJY3VDUC…
Bank of America reports indirect buys and sales in BNY Mellon fund (DSM) through Merrill Lynch. - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxQRVc5Wm9hWnhIWGdIRlRSZzJjbV9KZjJOemFQc3IzV2NyZkdZMWo4eEIwUGYxUzdGUW5Ma05Pb0lnNmZCSnNtdmt2Q3dqOHRhZWl2ME5zamFLYVVWVEVOTVNIVnJCWlMtSzY3NWdMeG9wakFBSl8yTWNNUGh1QTdXaWotS2x0bzVjSEFLeV…
BNY Mellon Strategic Municipal Bond Fund (NYSE:DSM) Stock: Insider Saba Capital Management, L.P. Purchases 20,575 Shares - MarketBeat
<a href="https://news.google.com/rss/articles/CBMihgJBVV95cUxNajRlMFlETVEtV1otc0ZlbnAxWVJkam40THk3WWhKVW80QzNfeUdERVN3aGE1ZGI2VU15cGxoR1ZVOFNhZWlMWk9ROUpmMzVGSzhqVEJnRXVPcm1ONk05SDd1QzBkMGdlYnVSN2JwNEFMR1laazRvZzNHS1lvUlVwdnJuTnZsWEMzNl9vZk…
Insider Stock Purchases: October 20, 2026 - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxNZmxleUZsc3lFcWxMRXFCd2I1VHIzaFBUSTNmLW9WTnFxeEg2dXNVTUdJVlZfdTN0R1BiOExfSmxvUGdfdVk0TFAwT191OGZnNnNBc2tkZm9oYTQ0eWVCSmpya2tYX0RJTE92NFNLWXR2TzV3RlpfUVAzWnQ5TEJoYVhDZV8?oc=5" targ…
How (DSM) Movements Inform Risk Allocation Models - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPM1ZPRVByd0lxQ0R3WU5Sc3VmSHNVS1Z1dXBfbGNVcTVjeGlZNlpyZDBCNjNmX284UzczNGZVY09ETUxiWmtPc1JsS2dCZ3JLOE1mYk5BQzBGdUpRblNLMjZaMC1ib2g0WTk2UHM4SHAwUkhwXzRQelFBRG9wdXJYTlIxVFJhU1p1a0pqZ3…
DSM — Frequently Asked Questions
What is the current share price of DSM?
As of 2026-10-23 16:27 PDT, DSM trades at $5.31 on NASDAQ/NYSE. Its 52-week range is $5.07 to $6.05.
What is the market capitalisation of DSM?
DSM has a market capitalisation of $262.47M on NASDAQ/NYSE.
What is the P/E ratio of DSM?
DSM trades at a trailing price-to-earnings (P/E) ratio of 8.05. Its price-to-book (P/B) ratio is 0.81.
What is the return on equity (ROE) of DSM?
DSM has a return on equity (ROE) of -1.70%.
Is DSM a good stock to buy?
This page provides a data-driven analysis of DSM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.